ProFund Advisors »

Akero Therapeutics shares owned by ProFund Advisors

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4M 29k 47.48
2025-06-30 $1.1M 20k 53.36
2025-03-31 $650k 16k 40.48
2024-12-31 $413k 15k 27.82
2024-09-30 $531k 19k 28.69
2024-06-30 $536k 23k 23.46
2024-03-31 $1.2M 46k 25.26
2023-09-30 $1.6M 31k 50.58
2023-06-30 $1.4M 29k 46.69
2023-03-31 $1.2M 31k 38.26